Summit Therapeutics, Inc. · 4 hours ago
Director, Clinical Scientist
Summit Therapeutics Inc. is a biopharmaceutical oncology company dedicated to improving quality of life and addressing serious unmet medical needs. The Director, Clinical Scientist will lead and contribute to the design and execution of clinical studies in hematology/oncology, collaborating with various teams to ensure exceptional delivery and interpretation of clinical data.
BiotechnologyHealth CareMedical DeviceTherapeutics
Responsibilities
Leads/Contributes to study design and amendments in collaboration with internal and external scientific stakeholders
Collaborates with MD, regulatory and other internal partners/stakeholders with authoring and submission of protocols, protocol amendments, regulatory filings, and other regulatory documentation
Collaborates with clinical operations, data management and CRO to develop and implement the overall data quality plan and leads internal medical data review and safety trend analysis on one or more studies/programs
Point-of-contact for clinical inquiries from CRO medical monitor and other stakeholders
Develops and provides input for clinical presentation slides and other materials for internal/external meetings and/or ongoing communications (e.g., investigator meetings, pre-study site selection visits, study coordinator or clinical research administrator training, study newsletters, communications to study sites, etc.)
Partners with clinical operations and CRO in developing and maintaining study start up documents/resources (e.g., ICF, Lab Manual, EDC, Safety monitoring Plan, etc.)
Participates in safety meetings and tracks, analyzes, and reviews documentation for any potential safety events
Leads/Contributes to the development and implementation of communications strategies to support existing and concluded studies. Includes KOL interactions, advisory boards, major medical meetings, congresses and other events, publications and other materials
Writes and/or reviews abstracts, posters, content for scientific meetings, conferences, other events and presentations, and other publicly distributed materials and coordinates further reviews with internal partners and stakeholders
Coordinates submissions to scientific meetings and/or other appropriate venues or groups
Writes clinical science sections of meeting packages and assists in the development and review of other clinical documentation required for regulatory submissions and other regulatory processes
All other duties as assigned
Qualification
Required
MS (or equivalent) required
Minimum of 5+ years overall related experience with PhD or like degree
Minimum of 2+ years' experience in conducting / supporting oncology/hematology clinical studies
Excellent written and verbal communication skills
Expertise in interpreting immunology/immuno-oncology translational data in addition to clinical data
Preferred
PhD, PharmD, or MD preferred
Benefits
Bonus
Stock
Benefits
Other applicable variable compensation
Company
Summit Therapeutics, Inc.
Summit Mission Statement: To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, as well as successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs.
H1B Sponsorship
Summit Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (6)
2023 (1)
Funding
Current Stage
Public CompanyTotal Funding
$1.79BKey Investors
CARB-XEurofarmaBiomedical Advanced Research and Development Authority (BARDA)
2025-10-21Post Ipo Equity· $500M
2024-09-11Post Ipo Equity· $235M
2024-06-03Post Ipo Equity· $200M
Recent News
2025-12-09
2025-12-05
Company data provided by crunchbase